News

BioXp™ Genomic Workstation Makes European Debut at VIB Research Institute in Belgium
22 August 2017
SGI-DNA Inc., a Synthetic Genomics Inc. company, and VIB today announced that VIB will become the first institute in Europe to integrate the BioXp™ 3200 System in its workflows as part of its vision for adopting breakthrough technologies.
After hours: Ann, Jermaine and Lawrence pedal for cancer awareness
18 August 2017
Three colleagues from VIB-KU Leuven – Ann Bouché, Jermaine Goveia and Lawrence Van Helleputte – share a common passion. Not only does their research contribute to the fight against cancer, all three are also fervent fans of cycling.
Scientists unravel role of glutamine synthetase in the spread of cancer
17 August 2017
A team led by Massimiliano Mazzone (VIB-KU Leuven) and Alessandra Castegna (University of Bari) has demonstrated a way to alter the metabolism of macrophages, a particular type of white blood cell often responsible for supporting tumor growth.
Navigation and spatial memory: new brain region identified to be involved
16 August 2017
Researchers at NERF (VIB-imec-KU Leuven) have now uncovered striking neural activity patterns in a brain area called the retrosplenial cortex that may assist with spatial memory and navigation.
Reporter on the road: keep the conversation going
14 August 2017
After completing her PhD at VIB, Liesbeth set out to explore new horizons and ended up at UNSW Australia. She writes about her scientific adventures on the other side of the world.
Check your favorite mouse genes in mousepost.be
8 August 2017
VIB scientists at Ghent University uncover and display (mousepost.be = mouse polymorphic sequence tags) the full richness of the mouse protein-coding genome for the mouse community.
Quickscan of VIBnews June 2017
4 August 2017
Articles of scientific publications
VIB spin-off Agrosavfe ready to conquer the world of biopesticides
4 August 2017
This spring VIB spin-off AgroSavfe welcomed seasoned manager and life sciences expert Luc Maertens as CEO. The company also extended its financing round, attracting a total of EUR 11 million with a major investment from Sofinnova Partners
VIB pushes the boundaries of science to develop new diagnostic tools
27 July 2017
With their world-leading strengths in molecular research and biotechnology, various VIB labs are paving the way for novel diagnostic tools that will reduce disease burden and save lives by making disease diagnosis better, faster and more flexible.
Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease
27 July 2017
For decades researches have been investigating the underlying foundations of Alzheimer’s disease to provide clues for the design of a successful therapy. VIB-KU Leuven scientists have published breakthrough insights in the prestigious journal Cell.
Pioneering work in London by Belgian 'cancer archeologist'
25 July 2017
Cancer researcher Peter Van Loo recently visited Belgium to accept the 2017 VIB Alumni Award. From his base at the prestigious Francis Crick Institute in London, Van Loo is mapping the history of tumors using mathematical algorithms and computers.
Specialized blood vessels enhance tumor-fighting immunotherapy
14 July 2017
Scientists from the VIB-KU Leuven Center for Cancer Biology, together with the University of California and the Swiss Institute for Experimental Cancer Research have demonstrated that anti-angiogenic therapy can improve immune boosting treatments.
Protein responsible for allergic diseases exposed
14 July 2017
Scientists at the VIB-UGent Center for Inflammation Research have managed to unravel the functioning of what is thought to be the ‘master protein’ that drives a range of widespread allergic diseases, such as asthma and eczema.
A-maize-ing new molecular discovery for agronomy
8 July 2017
In March 2017 scientists at the Dirk Inzé lab at the VIB-UGent Center for Plant Systems Biology unveiled a discovery critical to crop science – a gene called PLA1 that boosts plant growth and seed yield in maize.
A new unexpected key player in melanoma development identified
7 July 2017
Researchers from VIB-KU Leuven together with colleagues from INSERM report the important role for FES in the initiation and progression of melanoma that is notoriously quick to metastasize and that responds poorly to existing cancer treatments.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS